Published in Am J Physiol on August 01, 1970
Biliary excretion of lecithin and cholesterol in the dog. J Clin Invest (1972) 1.58
Bile acids: chemistry, physiology, and pathophysiology. World J Gastroenterol (2009) 1.51
Physiology of bile secretion. World J Gastroenterol (2008) 1.28
Studies of relationship among bile flow, liver plasma membrane NaK-ATPase, and membrane microviscosity in the rat. J Clin Invest (1979) 1.15
Effects of estrogen upon bile: implications with respect to gallstone formation. Ann Surg (1973) 1.11
Stimulation of hepatic sodium and potassium-activated adenosine triphosphatase activity by phenobarbital. Its possible role in regulation of bile flow. J Clin Invest (1977) 1.08
Cholangiocyte anion exchange and biliary bicarbonate excretion. World J Gastroenterol (2006) 1.08
The effect of thyroid hormone on bile salt-independent bile flow and Na+, K+ -ATPase activity in liver plasma membranes enriched in bile canaliculi. J Clin Invest (1976) 1.07
Canalicular bile secretion in man. Studies utilizing the biliary clearance of (14C)mannitol. J Clin Invest (1974) 0.99
Changes in mammary gland permeability at the onset of lactation in the goat: an effect on tight junctions? J Physiol (1973) 0.93
Relationship between bile flow and Na+, K+-adenosinetriphosphatase in liver plasma membranes enriched in bile canaliculi. J Clin Invest (1977) 0.93
Alteration of bile canalicular enzymes in cholestasis. A possible cause of bile secretory failure. J Clin Invest (1973) 0.91
Mechanisms and prediction of drug-induced liver disease. Gut (1973) 0.87
Aspects of bile secretion in the rabbit. J Physiol (1975) 0.86
Effects of phenobarbital and rose bengal on the ATPases of plasma membranes of rat and rabbit liver. Gut (1972) 0.85
Comparative effects of sodium taurodeoxycholate and sodium taurocholate on bile secretion in the rat, dog and rabbit. J Physiol (1975) 0.84
Species differences in the choleretic response to bile salts. J Physiol (1972) 0.84
Effect of somatostatin on determinants of bile flow in unanesthetized dogs. Ann Surg (1982) 0.80
Studies of the hepatic excretory defects in essential fatty acid deficiency. Their possible relationship to the genesis of cholesterol gallstones. J Clin Invest (1974) 0.79
Effect of truncal vagotomy on 2-deoxy-D-glucose and insulin choleresis. Ann Surg (1972) 0.79
Ursodeoxycholate stimulates Na+-H+ exchange in rat liver basolateral plasma membrane vesicles. J Clin Invest (1987) 0.77
Sodium taurocholate modifies the bile acid-independent fraction of canalicular bile flow in the rhesus monkey. J Clin Invest (1979) 0.77
Elaboration of hepatocytic bile. Bull N Y Acad Med (1975) 0.76
The choleretic effect of iodipamide. J Clin Invest (1975) 0.75
Proceedings: Direction selective sub-regions in striate simple cell receptive fields. J Physiol (1974) 0.75
The effect of sodium salicylate on bile secretion in the dog. J Physiol (1975) 0.75
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med (2001) 3.87
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med (1997) 3.49
Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group. Ann Intern Med (1995) 3.41
Delirium in an intensive care unit: a study of risk factors. Intensive Care Med (2001) 3.23
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (2000) 3.16
Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis (1995) 2.89
Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology (2001) 2.75
Arterial changes in the lungs in cirrhosis of the liver--lung spider nevi. N Engl J Med (1966) 2.65
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology (1999) 2.63
Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry (2005) 2.54
Eradication of hepatitis C virus RNA after alpha-interferon therapy. Ann Intern Med (1994) 2.11
Structure and expression of a new complementary DNA encoding the almost exclusive 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase in human adrenals and gonads. Mol Endocrinol (1991) 2.07
The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology (2001) 1.99
Mechanism of phenobarbital-induced hypercholeresis in the rat. Am J Physiol (1970) 1.99
Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. J Hepatol (1998) 1.91
Second generation (RIBA) test in diagnosis of chronic hepatitis C. Lancet (1991) 1.84
Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol (1998) 1.84
Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology (1995) 1.78
Hepatitis C virus in dermatology. A review. Arch Dermatol (1995) 1.71
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology (1998) 1.69
Focal nodular hyperplasia of the liver in men: is presentation the same in men and women? Gut (2002) 1.65
Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet (1992) 1.63
The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors. Am J Clin Pathol (1998) 1.59
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol (1998) 1.59
Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology (1997) 1.55
Epidemiological and virological analysis of couples infected with hepatitis C virus. Gut (1999) 1.55
The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology (1995) 1.54
Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med (1995) 1.53
Standardization of hepatitis C virus RNA quantification. Hepatology (2000) 1.52
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology (2001) 1.51
Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood (1999) 1.51
Hepatitis delta virus infection in French male HBsAg-positive homosexuals. Hepatology (1989) 1.51
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patients. Hepatology (1989) 1.50
Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology (2000) 1.49
Combined liver transplantation and pancreatoduodenectomy for irresectable hilar bile duct carcinoma. Br J Surg (1995) 1.48
Thoracic splenosis after blunt trauma: frequency and imaging findings. AJR Am J Roentgenol (1993) 1.48
Acute infusions of bile salts increase biliary excretion of iron in iron-loaded rats. Gastroenterology (1991) 1.46
Arthroplastic and osteosynthetic infections due to Propionibacterium acnes: a retrospective study of 52 cases, 1995-2002. Eur J Clin Microbiol Infect Dis (2005) 1.45
Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation. Hepatology (1999) 1.45
Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology (1987) 1.45
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med (1997) 1.44
Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer (2003) 1.44
Microsporidia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med (1993) 1.43
Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology (1996) 1.41
Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics (1996) 1.41
[The return of the GAS Mask. Reply of P. Berthelot, J.-C. Lucet, S. Aho, J. Hajjar to the article by O. Multon ]. Gynecol Obstet Fertil (2008) 1.40
Impact of smoking on histological liver lesions in chronic hepatitis C. Gut (2003) 1.40
Hypoprothrombinemia and cefotaxime. Am J Gastroenterol (1990) 1.38
Evidence that hepatitis B virus has a role in liver-cell carcinoma in alcoholic liver disease. N Engl J Med (1982) 1.37
Arbitrarily primed PCR, ribotyping, and plasmid pattern analysis applied to investigation of a nosocomial outbreak due to Enterobacter cloacae in a neonatal intensive care unit. J Clin Microbiol (1994) 1.36
What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology (1998) 1.36
Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology (1999) 1.35
Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease. J Clin Invest (1977) 1.35
High prevalence of hepatitis B, C, and E markers in young sexually active adults from the Central African Republic. J Med Virol (1995) 1.33
Circadian and homeostatic sleep regulation in morningness-eveningness. J Sleep Res (2006) 1.28
Effect of bunamiodyl on hepatic uptake of sulfobromophthalein in the rat. Am J Physiol (1966) 1.28
Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol (1999) 1.26
Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area. Hepatology (1993) 1.26
Routine detection and quantification of hepatitis B virus DNA in clinical laboratories: performance of three commercial assays. J Virol Methods (2000) 1.26
Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA. J Clin Microbiol (1994) 1.26
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology (1996) 1.26
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol (1998) 1.25
Heterotopic liver transplantation in end-stage HBsAg-positive cirrhosis. Lancet (1980) 1.21
Release of calcium from the endoplasmic reticulum by bile acids in rat liver cells. J Biol Chem (1988) 1.21
Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1992) 1.21
Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen. Behav Brain Res (2005) 1.20
What technique should be used for routine detection and quantification of HBV DNA in clinical samples? J Virol Methods (1997) 1.19
Induction of hepatic microsomal enzymes after brief administration of rifampicin in man. Gastroenterology (1977) 1.19
Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology (1995) 1.18
Significance of indeterminate third-generation hepatitis C virus recombinant immunoblot assay. J Clin Microbiol (1996) 1.18
Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology (1987) 1.18
Seasonal and diurnal patterns of human illumination under natural conditions. Chronobiol Int (1998) 1.17
Factor V Leiden related Budd-Chiari syndrome. Gut (2001) 1.17
Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol (1997) 1.16
Characteristics of bile acid-mediated Ca2+ release from permeabilized liver cells and liver microsomes. J Biol Chem (1989) 1.16
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol (2000) 1.15
Mechanisms and control of secretion of bile water and electrolytes. Gastroenterology (1974) 1.15
Ectopic hepatocellular carcinoma arising in the left chest wall: a long-term follow-up. Eur J Gastroenterol Hepatol (2001) 1.15
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol (1999) 1.15
Specific vaccine therapy in chronic hepatitis B infection. Lancet (1994) 1.15
Characterization of human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4-isomerase gene and its expression in mammalian cells. J Biol Chem (1990) 1.15
Factors affecting treatment responses to interferon-alpha in chronic hepatitis C. J Infect Dis (1996) 1.14
Hepatocellular uptake of taurocholate in the dog. J Clin Invest (1975) 1.14
In vivo and in vitro expression of defective hepatitis B virus particles generated by spliced hepatitis B virus RNA. Hepatology (1995) 1.13
Drug-induced vascular lesions of the liver. Arch Intern Med (1983) 1.13
Association of focal nodular hyperplasia and hepatic hemangioma. Gastroenterology (1989) 1.13
Mitogenic effect of transforming growth factor-beta 1 on human Ito cells in culture: evidence for mediation by endogenous platelet-derived growth factor. Hepatology (1993) 1.12
The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology (1993) 1.12
Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology (1993) 1.12